Topic: Valuation

Latest content

$1.9bn damages verdict against Cisco is the latest in a series of blockbuster wins for US patent owners

So far this year, there have been nine awards of over $100 million handed down by district courts - that's more than the number for 2017, 2018 and 2019 combined

06 October 2020

Elite patent owners in electronics sector saw big share price decline in August

The monthly IAM/ktMINE US Patent Elite share tracker finds top IP owners' stock performance falling behind their peers for the first time

30 September 2020

Oracle doesn’t talk patents that often, but maybe it should

Although the company keeps its cards close, it is not to be underestimated - and a TikTok deal would definitely increase its strength in the cloud

25 September 2020

Top IP owners in telecoms and semiconductors enjoy ongoing share advance

The latest numbers from the US Patent Elite index show stock price rises in both sectors continued into July

11 September 2020

Portfolio analysis shows BlackBerry’s new director of licensing has a lot to work with

The Canadian tech giant’s patents pack a punch and claims of a technologically diverse holding ring true, but slowing filing levels leave pipeline questions

11 September 2020

Pharma patent deal-making may be back with a bang

Following a spate of licensing deals, high-value life sciences M&A now seems to be back in business after a pandemic-induced pause

10 September 2020

The top 10 takeaways from this year’s Global Innovation Index

The latest edition of the annual WIPO publication reveals that Europe and North America still lead despite rising innovation levels in Asia

09 September 2020

Geely to boost R&D war chest with Shanghai listing

China’s next big IPO will feature one of the country’s auto IP leaders, which has more than 9,000 patents and counts licensing as a major revenue source

07 September 2020

Sanofi eyes more M&A as deals drive increase in IP portfolio quality

The French pharmaceutical’s holdings have shrunk over recent years and application output is at a low, but recent acquisitions have provided a boost while a patent revamp is around the corner

28 August 2020

Translational research key to realising value of university IP, says UCL biopharma chief

Dr Richard Fagan of University College London Business tells IAM about the process of turning patents for early-stage research into investable assets

27 August 2020

Get unlimited access to all IAM content